Unknown

Dataset Information

0

Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection.

ABSTRACT:

SUBMITTER: Kowdley KV 

PROVIDER: S-EPMC4567098 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection.

Kowdley Kris V KV   An Di D   Pang Phillip S PS   Wyles David D  

Open Forum Infectious Diseases 20150420 2

Similar Datasets

Unknown Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C.
| S-EPMC4324232 | biostudies-literature
Unknown Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C.
| S-EPMC4567096 | biostudies-literature
Unknown An evaluation of ledipasvir + sofosbuvir for the treatment of chronic hepatitis C infection.
| S-EPMC8478781 | biostudies-literature
Unknown Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.
| S-EPMC9945827 | biostudies-literature
Unknown Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.
| S-EPMC4782840 | biostudies-literature
Unknown Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection.
| S-EPMC5840188 | biostudies-literature
Unknown Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.
| S-EPMC7491553 | biostudies-literature
Unknown No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
| S-EPMC6276897 | biostudies-literature
Unknown Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient.
| S-EPMC8310846 | biostudies-literature
Unknown Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
| S-EPMC9427145 | biostudies-literature